WINDTREE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.105 USD | -3.41% |
|
-10.78% | -68.28% |
| Apr. 16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar Windtree Therapeutics, Inc.
69.gU7TkDtrbi48Ir6D8eoUm9qW6IBj8UZA71sQmtPHD64.8Xero3k5Gn0MctPcs4BV6Lza28govCckuhwn85aYVdfROrXEAg5eTEZnhg~8e8c12d8364e94347fbff5c11776729a
Upcoming events on Windtree Therapeutics, Inc.
Past events on Windtree Therapeutics, Inc.
| 2024-05-14 | Q1 2024 Earnings Release (Projected) |
| 2024-04-21 | Reverse Split: 1 of 18 |
| 2024-04-17 08:00 am | Q4 2023 Earnings Release |
| 2024-04-09 | Extraordinary Shareholders Meeting |
| 2023-11-16 01:45 pm | Sidoti Microcap Virtual Conference |
| 2023-11-09 04:15 pm | Q3 2023 Earnings Release |
| 2023-10-19 04:30 pm | ThinkEquity Conference |
| 2023-10-17 10:30 am | Lytham Partners Fall Investor Conference |
| 2023-10-11 | Dawson James Small Cap Growth Conference |
| 2023-08-15 09:00 am | Annual General Meeting |
| 2023-08-07 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-14 01:00 pm | Investor Day |
| 2023-05-15 04:30 pm | Q1 2023 Earnings Release |
| 2023-04-03 07:35 am | Q4 2022 Earnings Release |
| 2023-03-19 | Technology and Heart Failure Therapeutics Conference |
| 2023-02-23 | Reverse Split: 1 of 50 |
| 2023-02-06 | Extraordinary Shareholders Meeting |
| 2022-11-14 07:30 am | Q3 2022 Earnings Release |
| 2022-09-29 04:00 pm | Ladenburg Thalmann Healthcare Conference |
| 2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -30,3 -31,0 2.3% | -77,3 -71,0 -8.9% | 0,00 | -20,6 -20,5 -0.47% | -21,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -32,6 -32,9 1.11% | -77,6 -71,3 -8.93% | 0,00 | -20,3 -20,0 -1.46% | -21,6 |
|
Net income Million USD | Released Forecast Spread | -27,5 | -32,6 -32,6 0.13% | -67,6 -62,9 -7.45% | 0,00 | -20,3 -20,0 -1.46% | -21,6 |
|
EPS USD | Released Forecast Spread | -2 268 | -1 872 -1 885 0.72% | -2 457 -2 299 -6.85% | -1 120 | -94,3 -94,9 0.57% | -17,5 |
| Announcement Date | 03/04/20 | 29/03/21 | 31/03/22 | 03/04/23 | 16/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,03 - | 0,00 0,10 - | 0,00 0,03 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -8,33 -8,71 4.27% | -17,5 -8,00 -119.36% | -4,65 -7,95 41.51% | -4,19 -2,95 -42.07% | -6,76 -3,65 -85.12% | -4,69 -3,46 -35.55% | -4,96 -4,80 -3.31% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,13 -8,69 6.48% | -17,3 -7,98 -117.21% | -4,06 -7,94 48.88% | -4,11 -2,92 -40.79% | -6,60 -3,62 -82.35% | -4,43 -3,43 -29.01% | -5,15 -4,90 -5.18% | |
|
Net income Million USD | Released Forecast Spread | -8,13 -8,69 6.48% | -17,3 -7,98 -117.21% | -4,06 -7,94 48.88% | -4,11 -2,92 -40.79% | -6,60 -3,62 -82.35% | -4,43 -3,43 -29.01% | -5,15 -4,90 -5.18% | |
|
EPS USD | Released Forecast Spread | -261 -270 3.33% | -531 -162 -227.78% | -117 -234 50% | -234 | -85,7 -10,1 -750% | -29,5 -12,2 -141.18% | -15,5 -11,3 -36.51% | -13,3 -16,9 21.28% |
| Announcement Date | 05/05/22 | 11/08/22 | 14/11/22 | 03/04/23 | 15/05/23 | 07/08/23 | 09/11/23 | 16/04/24 |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Windtree Therapeutics, Inc.
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- WINT Stock
- Calendar Windtree Therapeutics, Inc.
